Aegis Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Aegis
Rating: 0
Author: MarketBeat

View the latest stock recommendations issued by analysts at Aegis. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Aegis' equity research team. MarketBeat is not affiliated with or endorsed by Aegis.

2 Analysts
Updated 5/26/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 7 Last 12 Months
Buy Ratings: 7 Last 12 Months
Sell Ratings: 0 Last 12 Months
Companies Covered: 7 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
ATAI Atai Beckley	$7.24 -0.3%	5/26/2026		Upgrade		Strong-Buy	View details for Aegis rating of Atai Beckley (NASDAQ:ATAI) on 5/26/2026
EMPD Volcon	$2.80 -3.1%	4/6/2026		Upgrade		Strong-Buy	View details for Aegis rating of Volcon (NASDAQ:EMPD) on 4/6/2026
ATAI Atai Beckley	$7.24 -0.3%	7/2/2025	David Bouchey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Aegis rating of Atai Beckley (NASDAQ:ATAI) on 7/2/2025
EMPD Volcon	$2.80 -3.1%	3/5/2025	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Aegis rating of Volcon (NASDAQ:EMPD) on 3/5/2025
GCT GigaCloud Technology	$50.28 -3.1%	8/14/2024	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Aegis rating of GigaCloud Technology (NASDAQ:GCT) on 8/14/2024
SERV Serve Robotics	$4.90 -1.8%	7/24/2024	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Aegis rating of Serve Robotics (NASDAQ:SERV) on 7/24/2024
CRNT Ceragon Networks	$2.18 -0.9%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Ceragon Networks (NASDAQ:CRNT) on 9/12/2023
DPRO Draganfly	$4.68 -4.3%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Draganfly (NASDAQ:DPRO) on 9/12/2023
ESCA Escalade	$20.26 +0.9%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Escalade (NASDAQ:ESCA) on 9/12/2023
GTEC Greenland Technologies	$0.81 +14.1%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Greenland Technologies (NASDAQ:GTEC) on 9/12/2023
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
RGR Sturm, Ruger & Company, Inc.	$37.31 -1.0%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for Aegis rating of Sturm, Ruger & Company, Inc. (NYSE:RGR) on 9/12/2023
RVSN Rail Vision	$5.00 -3.1%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Rail Vision (NASDAQ:RVSN) on 9/12/2023
SWBI Smith & Wesson Brands	$14.15 -1.3%	9/12/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Smith & Wesson Brands (NASDAQ:SWBI) on 9/12/2023
SKYA SkyAI, Inc. Common Stock	$1.00 +2.0%	5/9/2023		Initiated Coverage		Buy	View details for Aegis rating of SkyAI, Inc. Common Stock (NASDAQ:SKYA) on 5/9/2023
EMPD Volcon	$2.80 -3.1%	3/7/2023	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$8,640,000.00	Buy	View details for Aegis rating of Volcon (NASDAQ:EMPD) on 3/7/2023
IINN Inspira Technologies OXY B.H.N.	$0.98 -2.0%	1/25/2023		Boost Price Target	$10.00 ➝ $13.00	Buy	View details for Aegis rating of Inspira Technologies OXY B.H.N. (NASDAQ:IINN) on 1/25/2023
GCT GigaCloud Technology	$50.28 -3.1%	10/3/2022		Initiated Coverage	$26.00	Buy	View details for Aegis rating of GigaCloud Technology (NASDAQ:GCT) on 10/3/2022
DRIO DarioHealth	$7.36 -3.0%	8/18/2022		Lower Price Target	$400.00 ➝ $300.00	Buy	View details for Aegis rating of DarioHealth (NASDAQ:DRIO) on 8/18/2022
IMUX Immunic	$16.03 -0.2%	8/8/2022		Lower Price Target	$400.00 ➝ $350.00	Buy	View details for Aegis rating of Immunic (NASDAQ:IMUX) on 8/8/2022
STXS Stereotaxis	$1.39 +0.7%	7/12/2022		Initiated Coverage	$6.00	Buy	View details for Aegis rating of Stereotaxis (NYSEAMERICAN:STXS) on 7/12/2022
ICCC ImmuCell	$9.70 -3.5%	6/23/2022	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of ImmuCell (NASDAQ:ICCC) on 6/23/2022
TRVI Trevi Therapeutics	$18.48 +0.1%	3/29/2022		Initiated Coverage	$10.00	Buy	View details for Aegis rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/29/2022
MDWD MediWound	$13.39 -1.3%	3/21/2022		Lower Price Target	$63.00 ➝ $49.00	Buy	View details for Aegis rating of MediWound (NASDAQ:MDWD) on 3/21/2022
PSTL Postal Realty Trust	$22.72 -1.2%	3/21/2022		Initiated Coverage	$23.00	Buy	View details for Aegis rating of Postal Realty Trust (NYSE:PSTL) on 3/21/2022
EMPD Volcon	$2.80 -3.1%	2/15/2022	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$8,640,000.00	Buy	View details for Aegis rating of Volcon (NASDAQ:EMPD) on 2/15/2022
DRIO DarioHealth	$7.36 -3.0%	1/26/2022		Lower Price Target	$560.00 ➝ $500.00	Buy	View details for Aegis rating of DarioHealth (NASDAQ:DRIO) on 1/26/2022
CING Cingulate	$5.21 +2.4%	1/11/2022		Initiated Coverage	$180.00	Buy	View details for Aegis rating of Cingulate (NASDAQ:CING) on 1/11/2022
CMMB Chemomab Therapeutics	$1.92 +0.5%	12/7/2021		Initiated Coverage	$120.00	Buy	View details for Aegis rating of Chemomab Therapeutics (NASDAQ:CMMB) on 12/7/2021
SELF Global Self Storage	$5.27 -1.5%	11/16/2021		Boost Price Target	$6.25 ➝ $7.00	Buy	View details for Aegis rating of Global Self Storage (NASDAQ:SELF) on 11/16/2021
JRSH Jerash Holdings (US)	$5.64 +6.4%	11/15/2021	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Jerash Holdings (US) (NASDAQ:JRSH) on 11/15/2021
OLP One Liberty Properties	$24.25 +0.1%	11/10/2021		Boost Price Target	$35.00 ➝ $39.00	Buy	View details for Aegis rating of One Liberty Properties (NYSE:OLP) on 11/10/2021
UMH UMH Properties	$16.18 -1.6%	11/4/2021		Boost Price Target	$27.00 ➝ $30.00	Buy	View details for Aegis rating of UMH Properties (NYSE:UMH) on 11/4/2021
ORMP Oramed Pharmaceuticals	$4.57 +2.0%	11/2/2021		Boost Price Target	$20.00 ➝ $35.00	Buy	View details for Aegis rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 11/2/2021
IINN Inspira Technologies OXY B.H.N.	$0.98 -2.0%	11/1/2021		Boost Price Target	$9.00 ➝ $10.00	Buy	View details for Aegis rating of Inspira Technologies OXY B.H.N. (NASDAQ:IINN) on 11/1/2021
SACH Sachem Capital	$0.79	10/25/2021		Reiterated Rating	$8.00	Buy	View details for Aegis rating of Sachem Capital (NYSEAMERICAN:SACH) on 10/25/2021
KURA Kura Oncology	$11.28 +3.9%	9/30/2021		Lower Price Target	$12,250.00 ➝ $8,750.00	Buy	View details for Aegis rating of Kura Oncology (NASDAQ:KURA) on 9/30/2021
HROW Harrow	$39.47 -1.4%	9/23/2021		Initiated Coverage	$15.00	Buy	View details for Aegis rating of Harrow (NASDAQ:HROW) on 9/23/2021
CRNT Ceragon Networks	$2.18 -0.9%	9/15/2021		Initiated Coverage	$6.00	Buy	View details for Aegis rating of Ceragon Networks (NASDAQ:CRNT) on 9/15/2021
XOMA XOMA Royalty	$40.17	9/9/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$60.00 ➝ $56.00	Buy	View details for Aegis rating of XOMA Royalty (NASDAQ:XOMA) on 9/9/2021
IINN Inspira Technologies OXY B.H.N.	$0.98 -2.0%	8/26/2021		Initiated Coverage	$9.00	Buy	View details for Aegis rating of Inspira Technologies OXY B.H.N. (NASDAQ:IINN) on 8/26/2021
Porter flew 3,300 miles to investigate this system (Ad) Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. Watch the full investigation and decide for yourself
DRIO DarioHealth	$7.36 -3.0%	8/19/2021		Lower Price Target	$700.00 ➝ $560.00	Buy	View details for Aegis rating of DarioHealth (NASDAQ:DRIO) on 8/19/2021
ATAI Atai Beckley	$7.24 -0.3%	8/17/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$26.00 ➝ $27.00	Buy	View details for Aegis rating of Atai Beckley (NASDAQ:ATAI) on 8/17/2021
MDWD MediWound	$13.39 -1.3%	8/17/2021		Lower Price Target	$70.00 ➝ $63.00	Buy	View details for Aegis rating of MediWound (NASDAQ:MDWD) on 8/17/2021
JRSH Jerash Holdings (US)	$5.64 +6.4%	8/11/2021		Boost Price Target	$9.00 ➝ $11.00	Buy	View details for Aegis rating of Jerash Holdings (US) (NASDAQ:JRSH) on 8/11/2021
GOOD Gladstone Commercial	$12.97 +0.3%	8/10/2021		Boost Price Target	$23.00 ➝ $26.00	Buy	View details for Aegis rating of Gladstone Commercial (NASDAQ:GOOD) on 8/10/2021
OLP One Liberty Properties	$24.25 +0.1%	8/9/2021		Boost Price Target	$32.00 ➝ $35.00	Buy	View details for Aegis rating of One Liberty Properties (NYSE:OLP) on 8/9/2021
UMH UMH Properties	$16.18 -1.6%	8/5/2021		Boost Price Target	$25.00 ➝ $27.00	Buy	View details for Aegis rating of UMH Properties (NYSE:UMH) on 8/5/2021
ENTX Entera Bio	$2.90 +0.3%	7/12/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00	Buy	View details for Aegis rating of Entera Bio (NASDAQ:ENTX) on 7/12/2021
ATAI Atai Beckley	$7.24 -0.3%	7/8/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$26.00	Buy	View details for Aegis rating of Atai Beckley (NASDAQ:ATAI) on 7/8/2021
HELP Cybin	$11.57 -3.5%	7/8/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$9.00	Buy	View details for Aegis rating of Cybin (NASDAQ:HELP) on 7/8/2021
XOMA XOMA Royalty	$40.17	6/29/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$60.00	Buy	View details for Aegis rating of XOMA Royalty (NASDAQ:XOMA) on 6/29/2021
JRSH Jerash Holdings (US)	$5.64 +6.4%	6/22/2021		Boost Price Target	$8.00 ➝ $9.00	Buy	View details for Aegis rating of Jerash Holdings (US) (NASDAQ:JRSH) on 6/22/2021
ORMP Oramed Pharmaceuticals	$4.57 +2.0%	6/8/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$12.00 ➝ $20.00	Buy	View details for Aegis rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 6/8/2021
OLP One Liberty Properties	$24.25 +0.1%	6/7/2021		Initiated Coverage	$32.00	Buy	View details for Aegis rating of One Liberty Properties (NYSE:OLP) on 6/7/2021
SCYX SCYNEXIS	$5.09 -1.7%	6/7/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$320.00 ➝ $280.00	Buy	View details for Aegis rating of SCYNEXIS (NASDAQ:SCYX) on 6/7/2021
SELF Global Self Storage	$5.27 -1.5%	5/17/2021		Boost Price Target	$6.00 ➝ $6.25	Buy	View details for Aegis rating of Global Self Storage (NASDAQ:SELF) on 5/17/2021
GTEC Greenland Technologies	$0.81 +14.1%	5/13/2021		Initiated Coverage	$14.00	Buy	View details for Aegis rating of Greenland Technologies (NASDAQ:GTEC) on 5/13/2021
SELF Global Self Storage	$5.27 -1.5%	4/22/2021		Initiated Coverage	$6.00	Buy	View details for Aegis rating of Global Self Storage (NASDAQ:SELF) on 4/22/2021
IMUX Immunic	$16.03 -0.2%	4/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$550.00	Buy	View details for Aegis rating of Immunic (NASDAQ:IMUX) on 4/15/2021
GOOD Gladstone Commercial	$12.97 +0.3%	4/13/2021		Initiated Coverage	$23.00	Buy	View details for Aegis rating of Gladstone Commercial (NASDAQ:GOOD) on 4/13/2021
SCYX SCYNEXIS	$5.09 -1.7%	4/12/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$360.00 ➝ $320.00	Buy	View details for Aegis rating of SCYNEXIS (NASDAQ:SCYX) on 4/12/2021
SACH Sachem Capital	$0.79	4/1/2021		Boost Price Target	$5.00 ➝ $8.00	Buy	View details for Aegis rating of Sachem Capital (NYSEAMERICAN:SACH) on 4/1/2021
UMH UMH Properties	$16.18 -1.6%	3/29/2021		Initiated Coverage	$25.00	Buy	View details for Aegis rating of UMH Properties (NYSE:UMH) on 3/29/2021
ENTX Entera Bio	$2.90 +0.3%	3/22/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Buy	View details for Aegis rating of Entera Bio (NASDAQ:ENTX) on 3/22/2021
MDWD MediWound	$13.39 -1.3%	3/2/2021		Initiated Coverage	$70.00	Buy	View details for Aegis rating of MediWound (NASDAQ:MDWD) on 3/2/2021
ESCA Escalade	$20.26 +0.9%	2/25/2021	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$25.00 ➝ $28.00	Buy	View details for Aegis rating of Escalade (NASDAQ:ESCA) on 2/25/2021
ANIX Anixa Biosciences	$3.49 +9.7%	2/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Anixa Biosciences (NASDAQ:ANIX) on 2/15/2021
CHRN ChronoScale Corporation Common Stock	$22.19 +6.0%	2/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of ChronoScale Corporation Common Stock (NASDAQ:CHRN) on 2/15/2021
DARE Dare Bioscience	$0.81 -12.9%	2/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Dare Bioscience (NASDAQ:DARE) on 2/15/2021
ICCC ImmuCell	$9.70 -3.5%	2/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of ImmuCell (NASDAQ:ICCC) on 2/15/2021
ORMP Oramed Pharmaceuticals	$4.57 +2.0%	2/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 2/15/2021
SCYX SCYNEXIS	$5.09 -1.7%	2/15/2021	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of SCYNEXIS (NASDAQ:SCYX) on 2/15/2021
DRIO DarioHealth	$7.36 -3.0%	2/8/2021	Nathan Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$500.00 ➝ $700.00	Buy	View details for Aegis rating of DarioHealth (NASDAQ:DRIO) on 2/8/2021
KURA Kura Oncology	$11.28 +3.9%	2/3/2021		Boost Price Target	$10,500.00 ➝ $12,250.00	Buy	View details for Aegis rating of Kura Oncology (NASDAQ:KURA) on 2/3/2021
ORMP Oramed Pharmaceuticals	$4.57 +2.0%	1/27/2021		Boost Price Target	$6.00 ➝ $12.00	Buy	View details for Aegis rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 1/27/2021
GLSI Greenwich LifeSciences	$17.38 +3.5%	1/26/2021		Initiated Coverage	$75.00	Buy	View details for Aegis rating of Greenwich LifeSciences (NASDAQ:GLSI) on 1/26/2021
RDNW RideNow Group	$6.13 -3.5%	11/10/2020		Boost Price Target	$30.00 ➝ $60.00	Buy	View details for Aegis rating of RideNow Group (NASDAQ:RDNW) on 11/10/2020
JRSH Jerash Holdings (US)	$5.64 +6.4%	10/27/2020	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$8.00	Buy	View details for Aegis rating of Jerash Holdings (US) (NASDAQ:JRSH) on 10/27/2020
VTGN VistaGen Therapeutics	$0.26 -2.8%	10/8/2020		Initiated Coverage	$180.00	Buy	View details for Aegis rating of VistaGen Therapeutics (NASDAQ:VTGN) on 10/8/2020
KURA Kura Oncology	$11.28 +3.9%	10/1/2020		Reiterated Rating	$10,500.00	Buy	View details for Aegis rating of Kura Oncology (NASDAQ:KURA) on 10/1/2020
RGR Sturm, Ruger & Company, Inc.	$37.31 -1.0%	9/24/2020	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$70.00	Hold	View details for Aegis rating of Sturm, Ruger & Company, Inc. (NYSE:RGR) on 9/24/2020
SWBI Smith & Wesson Brands	$14.15 -1.3%	9/24/2020	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$23.00	Buy	View details for Aegis rating of Smith & Wesson Brands (NASDAQ:SWBI) on 9/24/2020
KURA Kura Oncology	$11.28 +3.9%	9/14/2020		Initiated Coverage	$10,500.00	Buy	View details for Aegis rating of Kura Oncology (NASDAQ:KURA) on 9/14/2020
ESCA Escalade	$20.26 +0.9%	9/9/2020	Rommel Dionisio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$25.00	Buy	View details for Aegis rating of Escalade (NASDAQ:ESCA) on 9/9/2020
DRIO DarioHealth	$7.36 -3.0%	8/17/2020		Initiated Coverage	$500.00	Buy	View details for Aegis rating of DarioHealth (NASDAQ:DRIO) on 8/17/2020
CHRN ChronoScale Corporation Common Stock	$22.19 +6.0%	8/3/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$195.00 ➝ $135.00	Buy	View details for Aegis rating of ChronoScale Corporation Common Stock (NASDAQ:CHRN) on 8/3/2020
RDNW RideNow Group	$6.13 -3.5%	7/28/2020		Initiated Coverage	$30.00	Buy	View details for Aegis rating of RideNow Group (NASDAQ:RDNW) on 7/28/2020
MDRR Medalist Diversified REIT	$11.74 +2.4%	7/16/2020		Reiterated Rating	$5.60	Buy	View details for Aegis rating of Medalist Diversified REIT (NASDAQ:MDRR) on 7/16/2020
ICCC ImmuCell	$9.70 -3.5%	7/13/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$14.00	Buy	View details for Aegis rating of ImmuCell (NASDAQ:ICCC) on 7/13/2020
DARE Dare Bioscience	$0.81 -12.9%	7/12/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy ➝ Market Perform	View details for Aegis rating of Dare Bioscience (NASDAQ:DARE) on 7/12/2020
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech
SACH Sachem Capital	$0.79	6/23/2020		Reiterated Rating	$4.00	Buy	View details for Aegis rating of Sachem Capital (NYSEAMERICAN:SACH) on 6/23/2020
ANIX Anixa Biosciences	$3.49 +9.7%	6/2/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Anixa Biosciences (NASDAQ:ANIX) on 6/2/2020
DARE Dare Bioscience	$0.81 -12.9%	6/2/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Dare Bioscience (NASDAQ:DARE) on 6/2/2020
ORMP Oramed Pharmaceuticals	$4.57 +2.0%	6/2/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Aegis rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 6/2/2020
SCYX SCYNEXIS	$5.09 -1.7%	5/31/2020	N. Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$360.00	Buy	View details for Aegis rating of SCYNEXIS (NASDAQ:SCYX) on 5/31/2020
CHRN ChronoScale Corporation Common Stock	$22.19 +6.0%	5/21/2020		Lower Price Target	$225.00 ➝ $195.00	Buy	View details for Aegis rating of ChronoScale Corporation Common Stock (NASDAQ:CHRN) on 5/21/2020
SAR Saratoga Investment	$18.72 -1.0%	5/12/2020	B. Zucker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$28.00 ➝ $18.00	Buy	View details for Aegis rating of Saratoga Investment (NYSE:SAR) on 5/12/2020
GNL Global Net Lease	$8.81 +0.6%	5/5/2020		Lower Price Target	$21.50 ➝ $18.50	Buy	View details for Aegis rating of Global Net Lease (NYSE:GNL) on 5/5/2020
AMRN Amarin	$14.01 -0.4%	5/4/2020		Boost Price Target	$180.00 ➝ $220.00	Buy	View details for Aegis rating of Amarin (NASDAQ:AMRN) on 5/4/2020
HRZN Horizon Technology Finance	$5.00 -0.2%	4/30/2020	B. Zucker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$13.20 ➝ $10.50	Buy	View details for Aegis rating of Horizon Technology Finance (NASDAQ:HRZN) on 4/30/2020

MarketBeat Community Rating for Aegis

MarketBeat's community ratings are surveys of what our community members think about Aegis and other research firms in the last 90 days. Vote "Outperform" if you believe Aegis's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Aegis's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES: 0 Believe will outperform the market
UNDERPERFORM VOTES: 0 Believe will underperform the market

Analysts at Aegis

Aegis' equity research team has issued ratings on 7 companies across 4 sectors over the past 12 months, covered by 2 analysts. The Aegis analysts below are listed by number of ratings issued in the last year.

Aegis Stock Coverage by Sector

Aegis concentrates its research most heavily in Healthcare (42.9%), Consumer Discretionary (28.6%) and Communication Services (14.3%). The chart below shows how Aegis' 7 rated companies are distributed across all 4 sectors it covers.

Healthcare
3 companies
42.9%
Consumer Discretionary
2 companies
28.6%
Communication Services
1 company
14.3%
Industrials
1 company
14.3%

Best & Worst Calls

Best Call
000000.0%
NYSEAMERICAN:DSS
Initiated Coverage • Oct 10, 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
NASDAQ:EMPD
Reiterated Rating • Mar 7, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

Aegis - Frequently Asked Questions

Aegis' analysts currently have buy-equivalent ratings on 7 companies. Recent upgrades to buy include Atai Beckley.

Aegis has the deepest coverage in Healthcare (42.9% of rated companies), Consumer Discretionary (28.6% of rated companies), Industrials (14.3% of rated companies) and Communication Services (14.3% of rated companies).

Aegis issued 7 ratings over the last 12 months across 7 companies â€” an average of roughly 1 rating actions per month. These include initiated coverage, reiterated rating and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Aegis analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Aegis uses Buy, Hold, and Sell as their equivalents.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?